Abstract
VGX-1027 is a novel, low molecular weight, immunomodulatory compound that has shown efficacy against a variety of immuno-inflammatory disease models in animals including autoimmune diabetes in NOD mice, collagen-induced arthritis and chemically induced inflammatory colitis. Here, we have studied the effects of VGX-1027 on the development of endotoxin-induced uveitis (EIU) in male Lewis rats, as a model of inflammatory ocular diseases in humans.
Originalsprog | Engelsk |
---|---|
Tidsskrift | British Journal of Pharmacology |
Vol/bind | 155 |
Udgave nummer | 5 |
Sider (fra-til) | 722-30 |
Antal sider | 9 |
ISSN | 0007-1188 |
DOI | |
Status | Udgivet - 1 nov. 2008 |